Plus deals involving Aculys/Neurelis, Xtalpi/Excelra, Abbisko/Lilly, Daiichi Sankyo/Cosette, Mitsubishi Tanabe/ADC Therapeutics and PersonGen/Transgene.

Brainsgate’s ISS500 can reportedly lessen stroke symptoms if put into use within 24 hours of the onset of symptoms. 

At the IATI Biomed conference held in Tel Aviv in May, Medtronic executives hint at an increasing focus on diagnostics, personalized medicine, and patient outcomes.

The International Stroke Conference, held in San Diego in February 2009, presented several device-based therapies and approaches that could offer improved outcomes for patients that suffer an acute ischemic stroke. The technologies discussed included mechanical thrombectomy devices, laser treatments, and combined therapy using ultrasound, microspheres, and thrombolytic drugs.